Benitec Biopharma Inc. Reports Earnings Results for the Full Year Ended June 30, 2021
September 20, 2021 at 08:01 am
Benitec Biopharma Inc. announced earnings results for the full year ended June 30, 2021. For the full year, the company announced total revenue was USD 59,000 compared to USD 102,000 a year ago. Operating loss was USD 13.596 million compared to USD 8.281 million a year ago. Net loss was USD 13.882 million compared to USD 8.274 million a year ago. Basic loss per share from continuing operations was USD 3.23 compared to USD 8.1 a year ago.